Institutional Manager · CIK 0000200406
JOHNSON & JOHNSON
NEW BRUNSWICK, NJ · File #028-20072
Latest AUM
$554.6M
Positions
17
Top-10 Concentration
98.4%
Filings
9
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| EXITED | Arrowhead Pharmaceuticals, Inc. | 04280A100 | -247,598 | -$8.5M | $0 |
| REDUCE | CVRx, Inc. | CVRX | -78,569 | -$557,840 | -$4.0M |
| EXITED | Adicet Bio, Inc. | 007002108 | -364,472 | -$295,295 | $0 |
| NEW | Adicet Bio, Inc. | ACET | +22,779 | +$191,803 | $0 |
| EXITED | BiomX Inc. | 09090D103 | -96,866 | -$50,855 | $0 |
| EXITED | Senseonics Holdings, Inc. | 81727U105 | -54,621 | -$23,804 | $0 |
| REDUCE | Contineum Therapeutics Inc. | CTNM | 0 | $0 | -$633,336 |
| REDUCE | Fate Therapeutics, Inc. | FATE | 0 | $0 | -$937,353 |
| REDUCE | Legend Biotech Corporation | LEGN | 0 | $0 | -$8.9M |
| REDUCE | Lyell Immunopharma, Inc. | LYEL | 0 | $0 | +$598,539 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202517 pos · $554.6M
- 13F HOLDINGS REPORTQ/E Sep 202520 pos · $503.7M
- 13F HOLDINGS REPORTQ/E Jun 202520 pos · $334.1M
- 13F HOLDINGS REPORTQ/E Mar 202520 pos · $341.9M
- 13F HOLDINGS REPORTQ/E Dec 202420 pos · $386.1M
- 13F HOLDINGS REPORTQ/E Sep 202420 pos · $427.3M
- 13F HOLDINGS REPORTQ/E Jun 202420 pos · $400.7M
- 13F HOLDINGS REPORTQ/E Mar 202422 pos · $4.41B
- 13F HOLDINGS REPORTQ/E Dec 202324 pos · $271.5M
Top 17 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | Protagonist Therapeutics Inc. | PTGX | 2,449,183 | $213.9M | 38.57% |
| 2 | Nanobiotix S.A. | NBTX | 5,623,816 | $130.0M | 23.44% |
| 3 | Rapport Therapeutics, Inc. | RAPP | 1,784,517 | $54.1M | 9.76% |
| 4 | MeiraGTx Holdings plc | MGTX | 6,641,064 | $52.8M | 9.52% |
| 5 | CVRx, Inc. | CVRX | 4,024,861 | $28.6M | 5.15% |
| 6 | Contineum Therapeutics Inc. | CTNM | 1,979,173 | $22.6M | 4.08% |
| 7 | Legend Biotech Corporation | LEGN | 814,586 | $17.7M | 3.19% |
| 8 | Xencor, Inc. | XNCR | 748,062 | $11.5M | 2.06% |
| 9 | Procept BioRobotics Corporation | PRCT | 357,939 | $11.3M | 2.03% |
| 10 | Fate Therapeutics, Inc. | FATE | 3,379,064 | $3.3M | 0.60% |
| 11 | Neumora Therapeutics, Inc. | NMRA | 1,849,445 | $3.3M | 0.60% |
| 12 | Rallybio Corporation | RLYB | 3,636,363 | $2.5M | 0.45% |
| 13 | Lyell Immunopharma, Inc. | LYEL | 41,165 | $1.3M | 0.23% |
| 14 | Vor Biopharma, Inc. | VOR | 53,732 | $702,815 | 0.13% |
| 15 | Nano-X Imaging Ltd. | NNOX | 158,852 | $444,786 | 0.08% |
| 16 | Standard BioTools, Inc. | LAB | 311,967 | $399,318 | 0.07% |
| 17 | Adicet Bio, Inc. | ACET | 22,779 | $191,803 | 0.03% |